Wiggins Stephen F 4

4 · Signify Health, Inc. · Filed Feb 17, 2021

Form 4

Period: 2021-02-12

Director

Transactions

Award
Class A Common Stock
2021-02-12+7,697,691→ 7,697,691 total
Award
Class A Common Stock
2021-02-12+4,048→ 4,048 total(indirect: By LLC)
Award
Class A Common Stock
2021-02-16+7,916→ 7,916 total
Award
Employee Stock Options (Right to Buy)
2021-02-12+111,583→ 111,583 total
Exercise: $1.74Exp: 2026-02-01→ Class A Common Stock (111,583 underlying)
Award
Employee Stock Options (Right to Buy)
2021-02-12+88,981→ 88,981 total
Exercise: $2.28Exp: 2028-01-01→ Class A Common Stock (88,981 underlying)

Footnotes (5)

[F1]These securities were acquired through the conversion prior to the completion of the Issuer's initial public offering of historical interests held by the reporting person in New Remedy Corp.
[F2]Represents a grant of restricted stock units on February 16, 2021 that will vest on the first anniversary of the grant date.
[F3]The stock options are fully vested.
[F4]The stock options are 75% vested as of the date hereof and vest with respect to the remaining 25% in equal installments on each three-month anniversary of January 1, 2021, until the stock options are fully vested on January 1, 2022.
[F5]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Documents

1 file